Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy La Jolla Pharmaceutical Company stock | $4.31
Own La Jolla Pharmaceutical Company stock in just a few minutes.
Fact checked
La Jolla Pharmaceutical Company is a biotechnology business based in the US. La Jolla Pharmaceutical Company shares (LJPC) are listed on the NASDAQ and all prices are listed in US Dollars. La Jolla Pharmaceutical Company employs 90 staff and has a trailing 12-month revenue of around USD$29.7 million.
How to buy shares in La Jolla Pharmaceutical Company
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for La Jolla Pharmaceutical Company. Find the stock by name or ticker symbol: LJPC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until La Jolla Pharmaceutical Company reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$4.31, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of La Jolla Pharmaceutical Company, depending on your broker.
- Check in on your investment. Congratulations, you own a part of La Jolla Pharmaceutical Company. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- LJPC shares summary
- Compare share dealing platforms
- Is LJPC stock a buy or sell?
- Stock performance over time
- Can I short LJPC shares?
- La Jolla Pharmaceutical Company's financials
- How volatile are LJPC shares?
- Does La Jolla Pharmaceutical Company pay a dividend?
- Have LJPC shares ever split?
- Other common questions
La Jolla Pharmaceutical Company share price
Use our graph to track the performance of LJPC stocks over time.La Jolla Pharmaceutical Company shares at a glance
Information last updated 2020-12-28.
| Latest market close | USD$4.31 |
|---|---|
| 52-week range | USD$3.36 - USD$9.38 |
| 50-day moving average | USD$4.5721 |
| 200-day moving average | USD$4.2965 |
| Wall St. target price | USD$10.67 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-5.922 |
Buy La Jolla Pharmaceutical Company shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy La Jolla Pharmaceutical Company stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
La Jolla Pharmaceutical Company price performance over time
Historical closes compared with the close of $4.31 from 2020-12-18
| 1 week (2021-01-07) | 3.86% |
|---|---|
| 1 month (2020-12-17) | 1.89% |
| 3 months (2020-10-16) | 5.38% |
| 6 months (2020-07-16) | -1.82% |
| 1 year (2020-01-16) | -45.48% |
|---|---|
| 2 years (2019-01-16) | -34.30% |
| 3 years (2018-01-16) | 28.51 |
| 5 years (2016-01-15) | 14.94 |
La Jolla Pharmaceutical Company financials
| Revenue TTM | USD$29.7 million |
|---|---|
| Gross profit TTM | USD$20.7 million |
| Return on assets TTM | -23.58% |
| Return on equity TTM | 0% |
| Profit margin | -205.86% |
| Book value | $-0.608 |
| Market capitalisation | USD$111.4 million |
TTM: trailing 12 months
Shorting La Jolla Pharmaceutical Company shares
There are currently 2.8 million La Jolla Pharmaceutical Company shares held short by investors – that's known as La Jolla Pharmaceutical Company's "short interest". This figure is 12.8% down from 3.2 million last month.
There are a few different ways that this level of interest in shorting La Jolla Pharmaceutical Company shares can be evaluated.
La Jolla Pharmaceutical Company's "short interest ratio" (SIR)
La Jolla Pharmaceutical Company's "short interest ratio" (SIR) is the quantity of La Jolla Pharmaceutical Company shares currently shorted divided by the average quantity of La Jolla Pharmaceutical Company shares traded daily (recently around 184466.11295681). La Jolla Pharmaceutical Company's SIR currently stands at 15.05. In other words for every 100,000 La Jolla Pharmaceutical Company shares traded daily on the market, roughly 15050 shares are currently held short.
However La Jolla Pharmaceutical Company's short interest can also be evaluated against the total number of La Jolla Pharmaceutical Company shares, or, against the total number of tradable La Jolla Pharmaceutical Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case La Jolla Pharmaceutical Company's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 La Jolla Pharmaceutical Company shares in existence, roughly 110 shares are currently held short) or 0.1566% of the tradable shares (for every 100,000 tradable La Jolla Pharmaceutical Company shares, roughly 157 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against La Jolla Pharmaceutical Company.
Find out more about how you can short La Jolla Pharmaceutical Company stock.
La Jolla Pharmaceutical Company share dividends
We're not expecting La Jolla Pharmaceutical Company to pay a dividend over the next 12 months.
Have La Jolla Pharmaceutical Company's shares ever split?
La Jolla Pharmaceutical Company's shares were split on a 1:50 basis on 14 January 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your La Jolla Pharmaceutical Company shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for La Jolla Pharmaceutical Company shares which in turn could have impacted La Jolla Pharmaceutical Company's share price.
La Jolla Pharmaceutical Company share price volatility
Over the last 12 months, La Jolla Pharmaceutical Company's shares have ranged in value from as little as $3.36 up to $9.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while La Jolla Pharmaceutical Company's is 2.9444. This would suggest that La Jolla Pharmaceutical Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.
La Jolla Pharmaceutical Company overview
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Frequently asked questions
More guides on Finder
-
How to buy Gold Royalty Corp (GROY) stock when it goes public
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
-
How to buy Bustle Digital Group (LJPC.US) stock when it goes public
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
-
How to buy Lucid Motors (LJPC.US) stock when it goes public
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
-
How to buy HF Foods Group stock | $7.55
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
-
How to buy Hannon Armstrong Sustainable Infrastructure Capital stock | $69.54
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
-
How to buy Griffin Industrial Realty stock | $65.9
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
-
How to buy FS Bancorp stock | $59.24
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
-
How to buy First Northwest Bancorp stock | $16.66
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
-
How to buy First National Corporation stock | $17.74
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
-
How to buy Farmers National Banc stock | $13.88
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
Ask an Expert